Showing results (1561-1570 of 2,102) with videos related to
Sort By:
Pageof 211
Hepatology (Baltimore, Md.)|May 12, 2019
CD8<sup>+</sup> T Cells Promote Maturation of Liver-Resident NK Cells Through the CD70-CD27 axisLu Bai, Hui Peng, Xiaolei Hao, et al.Journal of Hazardous Materials|December 28, 2025
A fluorescent probe based solid-state fluorophore for the detection of N<sub>2</sub>H<sub>4</sub> and its application in environmental samplesCong-Ping Cao, Qian Song, Chu-Yu-Hui Peng, et al.Angewandte Chemie (International Ed. in English)|July 2, 2025
Mathematical Double-Matrix Switchable Homochiral FerroelectricXian-Jiang Song, Yan Qin, Yong Ai, et al.Annals of Surgical Oncology|December 11, 2025
Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT TrialTiantian Zhang, Lishuo Shi, Liuying Jian, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 22, 2023
Incidence and risk factors of postoperative pulmonary complications after oral cancer surgery with free flap reconstruction: A single center studyChih-Jun Lai, Po-Yuan Shih, Ya-Jung Cheng, et al.Animal Bioscience|June 2, 2026
Lysophosphatidic acid-mediated enhancement of porcine oocyte chemical enucleation for somatic cell nuclear transferChi-Hong Wong, Shu-Ping Chang, Shu-Hui Peng, et al.Frontiers in Surgery|April 16, 2026
Cervical spondylosis with propriospinal myoclonus and vocalization: a case reportJin-Hui Peng, Bo-Wei Liang, Xiang-Hong Zeng, et al.Journal of Ovarian Research|November 27, 2014
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3Wei Wang, Yan Zhang, Ming Lv, et al.Journal of the American Chemical Society|September 25, 2025
Asymmetric Coordination Designed Heterocrown Ether Host-Guest Ferroelectrics with Ultrahigh <i>T</i><sub>c</sub>Xiao-Gang Chen, Yan-Ran Weng, Yao Zhang, et al.Frontiers in Immunology|October 2, 2023
AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responsesBi Meng, Xuan Zhao, Shuchang Jiang, et al.Pageof 211